We previously reported that truncation of the cytoplasmic domain of the macaque simian immunodeficiency virus SIVmac239 envelope glycoprotein enhanced its ability to induce cell fusion in a variety of cell lines. In the present study, we examined the expression of the full-length and truncated SIVmac239 envelope glycoprotein complex on cell surfaces. Using a membrane-impermeable reagent to biotinylate proteins on cell surfaces followed by immunoprecipitation, we found that under conditions in which the full-length TM protein could not be detected on the surfaces of CD4-positive or CD4-negative cell lines, the truncated TM protein was detected efficiently. In contrast, using a membrane-impermeable iodination reagent to label proteins on cell surfaces, we could detect both the full-length and truncated TM proteins. No difference between the full-length and truncated proteins was observed in the detection of the SU proteins in the biotinylation assay. Additionally, we used an assay in which SIV-specific antibodies are prebound to the native envelope proteins expressed on the cell surface and then the proteins are immunoprecipitated. Using this assay, we could not detect the truncated or full-length TM protein on the cell surface, whereas we could detect the SU subunits of both proteins. We also observed that the truncated TM protein formed more stable sodium dodecyl sulfate-resistant oligomers than the full-length TM protein did. These results indicate that truncation of the cytoplasmic domain of the SIVmac239 envelope glycoprotein affects the conformation of the external domain of the TM protein on the cell surface, even though the two proteins have no differences in the amino acid sequences of their external domains. This altered conformation could play a role in the enhanced fusion activity of the truncated SIV glycoprotein.
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Simian immunodeficiency virus of macaques (SIVmac) is a lentivirus which is closely related to the human immunodeficiency viruses (HIVs) (2, 4, 10) . The envelope glycoproteins of lentiviruses are synthesized as precursor proteins which are cleaved by a cellular protease into the surface (SU) and the transmembrane (TM) subunits (19, 46) . The functions of the SU protein include binding to the cellular CD4 receptor (31) , while the TM protein contains a hydrophobic domain at its amino terminus which plays an important role in the membrane fusion activity of the envelope protein (12, 25) . The SU protein is noncovalently attached to the TM protein, which also functions as a membrane anchor through its hydrophobic membrane-spanning domain (20) . The envelope proteins of lentiviruses contain a long cytoplasmic domain of over 150 amino acids, the precise function of which has not been determined. Two amphipathic helices toward the C-terminal end of the cytoplasmic domain have been suggested to interact with membranes (17, 18, 42, 44) . In contrast to lentiviruses, the envelope proteins of other retroviruses have relatively short cytoplasmic domains. For instance, the cytoplasmic domain of the Rous sarcoma virus transmembrane protein is composed of 22 amino acids (35) and that of murine leukemia virus (MuLV) is composed of 32 amino acids (36) . Interestingly, in MuLV virions, the terminal 16 amino acids are proteolytically removed from the cytoplasmic tail of the MuLV glycoprotein, apparently by the viral protease (3, 15) .
Several infectious molecular clones of SIVmac were reported to contain premature termination codons in their TM proteins which resulted in deletions of most of their cytoplasmic tails (28, 29, 33) . The cytoplasmic domains of the mutant TM proteins were shortened to fewer than 20 amino acids. Interestingly, the size of such shortened cytoplasmic domains is similar to that of the Rous sarcoma virus and cleaved MuLV transmembrane proteins. It was further reported that prolonged passage in human cell lines selected for viruses containing a truncated transmembrane protein, while minimally passaged SIVmac possessed the full-length glycoprotein (1, 21) . Furthermore, when clones containing the premature env termination codons were used to infect monkey cells, reversion to a wild-type open env reading frame occurred (21, 24) . Interestingly, rhesus macaques infected with SIVmaclAl 1, possessing a truncated TM protein, developed a transient viremia but did not develop a clinical disease, while animals infected with SIVmac239, possessing a full-length TM protein, developed a progressive AIDS-like illness which ultimately resulted in death (23, 29, 30) . In contrast to SIV, only one example of an infectious HIV-1 isolate possessing a truncated envelope protein has been reported (41) . This isolate, which has a transmembrane domain shortened by 133 amino acids, apparently arose by adaptation to TALL-1 cells after prolonged coculture of the parental virus (41) .
We recently reported that truncation of the cytoplasmic domain of the SIVmac239 TM protein resulted in increased syncytium formation relative to that of the full-length envelope protein in several cell lines infected with recombinant vaccinia viruses expressing the wild-type or mutant envelope protein (39 Cell surface biotinylation and SDS-PAGE. The procedure used was similar to that described by Le Bivic et al. (27) . At Cell surface iodination. Confluent HeLa T4 cells were infected with recombinant vaccinia viruses as described above.
At the selected time points, the cells were washed three times with ice-cold PBS. The cells were then iodinated by using a modified Bolton-Hunter method as described by Thompson et al. (43) . To 3 jil of a 0.2-mg/ml stock solution of sulfo-SHPP (Pierce), the following reagents were added sequentially: 3 p.1 of 100-mCi/ml Na'251, 10 pul of chloramine T (5-mg/mi stock solution in 0.5 M sodium phosphate), 100 pI of hydroxyphenylacetic acid (1 mg/ml in water), and 10 pL. of sodium metabisulfate (12 mg/ml in 0.05 M sodium phosphate). This solution was added to 500 pI. of ice-cold PBS, mixed, and applied to the HeLa T4 cells for 30 min on ice. The reaction was terminated by three washes with ice-cold PBS containing 1 mg of lysine per ml. The cells were then lysed in lysis buffer including protease inhibitors (see above). The samples were immunoprecipitated with an SIV-specific antiserum from an infected rhesus monkey as described above, and the proteins were characterized by SDS-PAGE and autoradiography.
Prebinding of SIV-specific antibodies to cells expressing the native glycoproteins followed by lysis and immunoprecipitation. The procedure used was similar to that described by Gabuzda et al. (11) . The antiserum used was obtained from seroconverted rhesus macaques inoculated with live SIV and therefore should have included at least a subset of antibodies directed against the native (nondenatured) protein. Confluent HeLa T4 cells were infected with recombinant vaccinia viruses and radiolabeled with [35S]cysteine/methionine as described above. At the end of the labeling periods, the cells were washed twice with ice-cold PBS containing 2% fetal calf serum, incubated for 30 min at 4°C with a 1:800 dilution of an SIV-specific polyclonal antiserum from seropositive macaques, washed three times with ice-cold PBS containing 2% fetal calf serum, and incubated in lysis buffer for 45 min at 4°C. The cell lysate was then clarified by centrifugation and immunoprecipitated by incubation with protein A-agarose for 1 h at 4°C. Proteins were characterized by SDS-PAGE and autoradiography.
RESULTS
Cell surface biotinylation reveals differences in the fulllength and truncated SIVmac239 TM proteins. We have previously shown that truncation of the cytoplasmic tail of the SIVmac239 TM protein greatly increases syncytium formation in HeLa T4 cells (39) . To further investigate the mechanism for the observed differences in syncytium-forming ability of the wild-type and truncated SIVmac239 envelope proteins, we used a cell surface biotinylation assay (27) to detect the SIV glycoprotein species on the cell surface. HeLa T4 cells infected with rVV-239env or rVV-239T were radiolabeled for 15 min. After a chase period of 0, 1, 3, or 5 h, the cell surface proteins were biotinylated at 4°C. SIV-specific proteins present in culture media and in cell lysates were detected by immunoprecipitation with a polyclonal antibody specific to SIV. Biotinylated SIV-specific proteins on the cell surface were detected by incubating one aliquot of the cell lysate immunoprecipitate with streptavidin. At the end of the pulse, the uncleaved precursor protein was present in the cell lysate fraction of cells expressing either the full-length (Fig. 1A) or truncated ( Fig.  1B ) SIV protein. At the indicated chase points, processed envelope bands also appeared in the cell lysate immunoprecipitates, corresponding to the full-length and truncated SU and TM proteins. Processed precursors first appeared after the 1-hour chase and were found in progressively increased amounts after 3-and 5-h chases. The levels of unprocessed precursor proteins decreased correspondingly during the chases. Low levels of processed SU protein were detected by cell surface biotinylation in the 1-h chase samples. Higher levels of SU protein then accumulated on the cell surface, as can be seen in the 3-and 5-h chases. A small amount of the glycoprotein precursor also was detected by cell surface biotinylation with both full-length and truncated envelope proteins. At the end of the chase periods, the cell surface proteins were biotinylated. SIV-specific proteins released into the culture medium and in the cell lysate were immunoprecipitated with a polyclonal SIV antiserum. SIV-specific proteins (pre, envelope precursor; SU, surface subunit; TM, transmembrane subunit) on the cell surface were detected by precipitating half of the cell immunoprecipitate with streptavidin-agarose beads as described in Materials and Methods. Electrophoretic mobilities of prestained molecular weight standards are indicated. Lanes C represent samples from vaccinia virus-infected control cells.
Importantly, there were no apparent differences in the kinetics of surface appearance of the SU proteins of the truncated and full-length recombinants.
A striking difference between the full-length and truncated molecules was observed in the biotinylated TM proteins on the cell surface. The TM protein of the truncated SIVmac239 variant was detected on the cell surface at high levels in the 3-h chase sample and accumulated further after 5 h (Fig. 1B) . In contrast, the full-length TM protein was not detected by cell surface biotinylation (Fig. 1A) even though it was present in the cell lysates. These results show that the truncation of the cytoplasmic tail markedly increases the ability to detect the SIVmac239 TM protein on the cell surface by the biotinylation procedure.
The finding that the SU protein was detected on cell surfaces Similar levels of the full-length and truncated TM proteins can be detected on the cell surface by iodination. The results described above suggested that the full-length TM protein may have been present on the cell surface, since it is thought to be required to anchor the SU subunit to the cell. It therefore seemed possible that truncation of the TM protein induced a conformational change in the SU-TM protein complex which enabled a more efficient reaction between the biotinylation reagent (NHS-SS-Biotin) and the TM protein on the cell surface. To examine the cell surface expression of the fulllength and truncated SIV envelope proteins by a different approach, we used an iodination assay which has previously been shown to specifically label proteins present on the cell surface (43) . Two sets of HeLa T4 cells were infected with rVV-239env or rVV-239T. One set of cells was iodinated at 19 h postinfection. A parallel set of cells was metabolically labeled with [35S]cysteine/methionine at 12 h postinfection, chased for 7 h, and biotinylated. All cells were then lysed, SIV envelope proteins were immunoprecipitated with a polyclonal antibody to SIV, and half of the cell immunoprecipitate was incubated with streptavidin to detect biotinylated SIV-specific proteins on the cell surface. As with the results described above, only the truncated TM protein was efficiently detected on the cell surface with the biotinylation assay (compare lanes 4 and 5 in Fig. 2 ). In contrast, both the truncated and full-length TM proteins were labeled at high levels by the iodination procedure, indicating that both TM proteins are expressed on the cell surface (compare lanes 7 and 8 in Fig. 2) . The relative amounts of SU and TM proteins detected on the cell surface by the iodination procedure were similar for the full-length and truncated SIV envelope proteins.
Taken together, the results indicate that both the full-length and truncated SIV TM proteins are efficiently expressed on the cell surface, but cytoplasmic domain truncation causes a conformational difference which alters the accessibility of the TM protein to biotinylation.
The truncated and full-length TM proteins are not detected on cell surfaces by prebinding antibodies to cells expressing native envelope complexes followed by immunoprecipitation. To further examine the SIV envelope complex on cell surfaces, we used an assay in which SIV-specific antibodies are prebound to the native envelope proteins expressed on the cell surface and then subjected to lysis and immunoprecipitation (11) . HeLa T4 cells were infected with rVV-239env or rVV-239T and radiolabeled as described above. SIV envelope proteins accessible to antibodies on cell surfaces were precipitated by incubating the cells at 4°C with an SIV-specific antiserum as described in Materials and Methods. As shown in Fig. 3 , the SU proteins of both the full-length and truncated SIV envelope complexes could be precipitated on cell surfaces by this method. In contrast, neither full-length nor truncated TM protein was precipitated by this procedure, even though both were efficiently precipitated in the cell lysates of a parallel set of infected HeLa T4 cells (compare lanes 1 and 3 in Fig. 3A and B). These results indicate that in native glycoproteins The truncated SIV TM protein forms more stable SDSresistant oligomers than the full-length TM protein does. In the experiments reported above, an SIV-specific band with a molecular mass of about 60 kDa (as determined by plot analysis of protein markers) was observed in cells expressing the truncated SIV envelope glycoprotein (Fig. 2, lanes 2 and 8) but not the full-length protein. To determine whether this band corresponded to an oligomeric form of the truncated TM protein or whether it might be a degradation product of the SU protein, we infected HeLa T4 cells with a recombinant vaccinia virus expressing the truncated SIV envelope glycoprotein. At 14 h postinfection, the cells were iodinated as described above, and subsequently the cell lysate was immunoprecipitated with a polyclonal SIV antiserum or a monoclonal antibody against the SIV TM or SU protein (Fig. 4) . The polyclonal antiserum recognized the SU protein, the monomeric TM protein, and the 60-kDa band (lane 2). The monoclonal antibody against the TM protein recognized both the monomeric TM protein and the 60-kDa band and had no cross-reactivity with the SU protein (lane 3). The monoclonal antibody against the SU protein recognized only the SU protein and had no crossreactivity with the monomeric TM protein or the 60-kDa band (lane 4). This result indicates that the 60-kDa band is an SDS-resistant oligomeric form of the truncated TM protein which is present on the cell surface. Similar oligomers have been seen by other investigators in SIV and HIV-2 virions (38) . Interestingly, the oligomer can be dissociated by boiling for 10 min in 10% SDS (lane 1). Under nonreducing conditions, an oligomeric form of the full-length TM protein can be seen as a band of about 115 kDa (data not shown). The sizes of 115 kDa for the full-length TM protein and 60 kDa for the truncated TM protein suggest that the TM protein of SIVmac239 may form trimers, although this cannot be concluded with certainty from the relationship between apparent molecular weights. Under reducing conditions, the oligomeric form of the full- 3) and on the cell surface (lanes 4 to 6) were detected as described for Fig. 1 . Lanes 3 and 6 represent samples from vaccinia virus-infected control cells. TM (fl), full-length TM; TM (tr), truncated TM. length TM protein is usually not detectable or barely detectable compared with the truncated TM protein (data not shown). These results indicate that the truncated TM protein forms more stable oligomers than the full-length TM protein does.
Truncation of the SIV envelope protein alters its conformation on the surfaces of H9 cells. To examine the expression of the full-length and truncated SIV envelope glycoproteins in a CD4-positive T-cell line, we infected H9 cells with rVV-239env or rVV-239T. The infected cells were pulse-labeled, chased for 4 h, and biotinylated as described above. As shown in Fig. 5 , the SU proteins of both the full-length and truncated envelope constructs were detected at high levels on the surfaces of H9 cells. As seen in HeLa T4 cells, the truncated TM protein was readily detected on the cell surface, whereas only a very low level of the full-length TM protein was biotinylated. Interestingly, the levels of the truncated TM protein detected in the total cell fraction and the biotinylated fraction were very similar (compare lanes 2 and 5 in Fig. 5 ). This finding suggests that virtually all of the truncated TM protein in the cell is transported to the cell surface 4 h after synthesis of the envelope precursor. In contrast, in HeLa T4 cells, only a fraction of the truncated TM protein was detected on the cell surface by biotinylation (compare lanes 2 and 5 in Fig. 2) . These results indicate that the conformational differences in the SIV envelope protein observed on the surfaces of HeLa cells are also present on the surfaces of T cells.
DISCUSSION
Recent studies in our laboratory showed that a truncated SIVmac239 envelope protein was able to efficiently fuse HeLa T4 cells, while the full-length SIVmac239 envelope protein showed a complete lack of fusion in HeLa T4 cells (39) . In several CD4-positive T-cell lines, the truncated SIVmac239 envelope protein was also found to be more effective in inducing cell fusion. The present study was undertaken to compare the kinetics of surface appearance of glycoproteins with truncated or full-length cytoplasmic tails as well as the expression and conformation of individual SU and TM proteins present on cell surfaces. We have found no major differences in the cell surface expression levels of the SU subunits of the full-length or truncated SIV envelope protein. (7, 16, 34, 37, 45) . Given (6, 11) . Dubay et al. (6) reported that this decrease in viral infectivity was accompanied by a decreased incorporation of the envelope proteins into virions. Studies by Gabuzda et al. (11) also indicated that the decreased viral replication seen in cells infected with HIV-1 carrying truncated envelope proteins was due to a defect in viral entry. Evidence has been obtained that truncated HIV-1 envelope proteins are efficiently transported to the cell surface (9, 11) . In the case of SIV, viruses containing deletions of most of the cytoplasmic tail of the envelope protein were recovered from human cell lines (1, 21 (1) . SIV virions with truncated envelope proteins were also able to efficiently infect monkey cells (22) . However, in monkey cells infected with viruses expressing the truncated SIV envelope proteins, reversion of the truncated to the full-length envelope protein could occur (21, 24) . Interestingly, deletions in the cytoplasmic tail of the SIV envelope glycoprotein were accompanied by an increased incorporation of envelope proteins on the mutant virus particles (22, 48) . Several studies showed that truncation of the HIV and SIV envelope glycoproteins caused an increase in syncytium formation in CD4-positive cells expressing the truncated envelope proteins (9, 11, 32, 39, 48 
